Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.

已完结 10 由北大西大发布于 2026/10/29 10:02:57

DOI:10.1016/S1470-2045(24)00100-1
作者：Jean-Pascal Machiels,?Yungan Tao,?Lisa Licitra,?Barbara Burtness,?Makoto Tahara,?Danny Rischin,?Gustavo Alves,?Iane Pinto Figueiredo Lima,?Brett G M Hughes,?Yoann Pointreau,?Sercan Aksoy,?Simon Laban,
文献类型：期刊论文
补充材料：只需要正文

Elsevier

Abstract：Background: Despite multimodal therapy, 5-year overall survival for locally advanced head and neck squamous cell carcinoma (HNSCC) is about 50%. We assessed the addition of pembrolizumab to

应助信息

18小时前

Book学术机器人

d4251a786f7c11f1a48934735aa3bc31.pdf 已采纳

18小时前

Book学术机器人

2026/10/29 10:02:57 Book学术AI机器人已找到文献并上传

2026/10/29 10:02:57 Book学术AI机器人收到请求，开始寻找文献

2026/10/29 10:02:57 已向机器人发送请求

18小时前

北大西大发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:NatureSpatially offset Raman spectroscopy